Humanigen Inc. (HGEN) Appoints John Hohneker to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. FLG
4. GMAB
5. ACCV
6. TSLA
7. SPCX
8. XNCR
9. AZN
10. APO

Go back to Humanigen Inc. (HGEN) Appoints John Hohneker to its Board

Humanigen Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors

October 20, 2021 7:00 AM EDT

BURLINGAME, Calif.--(BUSINESS WIRE)-- Humanigen, Inc. (Nasdaq: HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm, announced today that the Companys Board of Directors (the Board) has elected John Hohneker, MD, and Kevin Xie, PhD, to serve as independent directors of the Company, effective October 19, 2021.

We are excited about the depth and breadth of experience John and Kevin will add to our Board at this important time as we continue our efforts seeking regulatory authorization to commercialize lenzilumab for the treatment of hospitalized COVID-19 patients, while... More